Texas Top Legal Officer Sues Tylenol Makers Regarding Autism Spectrum Assertions

Legal Proceedings
Ken Paxton, a Trump ally campaigning for US Senate, claimed pharmaceutical manufacturers of concealing potential dangers of acetaminophen

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, asserting the companies hid alleged dangers that the drug posed to pediatric brain development.

The court filing comes a month after Former President Trump promoted an unsubstantiated connection between using Tylenol - referred to as acetaminophen - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which once produced the drug, the sole analgesic approved for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he stated they "betrayed America by gaining financially from pain and pushing pills without regard for the dangers."

The manufacturer states there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening millions to increase profits," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "very worried by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, the company also said it had "regularly reviewed the pertinent research and there is no credible data that shows a proven link between taking acetaminophen and autism spectrum disorder."

Organizations speaking for physicians and healthcare providers concur.

ACOG has said acetaminophen - the primary component in Tylenol - is among limited choices for expectant mothers to treat discomfort and fever, which can present major wellness concerns if ignored.

"In over twenty years of research on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the consumption of paracetamol in any period of gestation leads to neurodevelopmental disorders in children," the group commented.

This legal action mentions latest statements from the former administration in claiming the drug is allegedly unsafe.

Last month, Trump generated worry from health experts when he told women during pregnancy to "struggle intensely" not to take Tylenol when unwell.

Federal regulators then published an announcement that doctors should contemplate reducing the usage of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in children has not been proven.

The Health Department head RFK Jr, who supervises the FDA, had vowed in April to initiate "comprehensive study program" that would identify the origin of autism spectrum disorder in a short period.

But experts warned that finding a single cause of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of genetic and external influences - would prove challenging.

Autism is a type of permanent neurological difference and impairment that affects how persons perceive and engage with the surroundings, and is diagnosed using doctors' observations.

In his legal document, Paxton - who supports Trump who is running for federal office - asserts the manufacturer and Johnson & Johnson "willfully ignored and sought to suppress the research" around acetaminophen and autism.

The lawsuit seeks to make the companies "destroy any commercial messaging" that asserts acetaminophen is secure for women during pregnancy.

The Texas lawsuit echoes the grievances of a assembly of mothers and fathers of young ones with autism and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

A federal judge threw out the lawsuit, stating studies from the plaintiffs' authorities was inconclusive.

Shannon Mclaughlin
Shannon Mclaughlin

Elara is a cybersecurity expert with over a decade of experience in network security and proxy technologies, dedicated to enhancing online privacy.